Traditional MedicareCoverageMedium impact
GlycoMark® Testing for Glycemic Control
Medicare/CMS - LCD·Endocrinology, Family Medicine, Internal Medicine·Local Coverage Determination
Effective date
Apr 2, 2026
We identified it
Jun 17, 2026
Summary
This is a new Local Coverage Determination (LCD) establishing coverage rules for GlycoMark® Testing for Glycemic Control under Medicare Part A and Part B. The policy defines when this specialized diabetes monitoring test will be covered by Medicare, effective April 2, 2026.
Action Required
By April 2, 2026: Billing team must review the full LCD L36906 policy to understand coverage criteria for GlycoMark® testing. Update billing system with appropriate CPT codes and coverage requirements. Ensure providers understand documentation requirements for medical necessity. Claims submitted without meeting LCD criteria will be denied.